Top Markets
Coin of the day
MetaStat Inc MetaStat Inc

MetaStat Inc

MTST
Rang in aandelen #42020
MetaStat, Inc., a precision medicine company, focuses on discovering and... MetaStat, Inc., a precision medicine company, focuses on discovering and developing therapeutic and diagnostic treatment solutions for cancer patients. The company is developing novel drug candidates and companion diagnostic tests that target the MENA pathway. Its product candidates include MENA diagnostic assay, a tissue-based quantitative immunofluorescence test that measures expression of the pro-metastatic MENA protein splice-variant; companion diagnostic to predict RTK inhibitor drug responses and anti-microtubule drug responses; liquid blood-based biopsy to enhance cancer diagnosis and optimize patient care; MetaSite Breast assay, an immunohistochemistry test that measures micro-anatomical intravasat at blood vessels within the tumor microenvironment ion sites; and prognostic diagnostic to predict risk of cancer metastasis. The company’s therapeutic targets a critical metastatic pathway in solid tumors responsible for driving tumor resistance and the spread of aggressive cancer. MetaStat, Inc. is based in Boston, Massachusetts.
Aandeelprijs
$0.001
Laatst gesynchroniseerd: 2026-08-11
Marktkapitalisatie
$5.88K
Verandering (1 dag)
0.00%
Verandering (1 jaar)
400.00%
Land
US
Handel MetaStat Inc (MTST)

Categorie

Koersgeschiedenis voor MetaStat Inc (MTST)
Hoogste slotkoers: $0.00 op 2026-08-01

Laagste slotkoers: $8.64K op 2009-01-01
Koersgeschiedenis van MetaStat Inc van 2009 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) 0.00%
2025 463.64%
2024 0.00%
2023 0.00%
2022 -94.49%
2021 -97.16%
2020 -66.02%
2019 -80.17%
2018 -86.53%
2017 -59.23%
2016 -66.02%
2015 -30.12%
2014 -67.24%
2013 -59.82%
2012 145.63%
2011 -91.79%
2010 111.42%
2009 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$57.00 49.47%
CN
$108.57 62.31%
CH
$460.07 28.69%
IE
$287.89 109.53%
US
$8.66 81.64%
TH